Tivic Health’s CEO Invited to Present at the 148th National Investment Banking Association Conference

August 2022

SAN FRANCISCO, CA – August 30, 2022 Tivic Health® Systems, Inc. (Nasdaq: TIVC), a commercial-phase health technology company that develops and commercializes bioelectronic medicine, today announced that the company’s CEO will present at the upcoming 148th National Investment Banking Association conference.

 

WHO:              Jennifer Ernst, Chief Executive Officer

WHAT:             The National Investment Banking Association Conference

WHERE:           Margaritaville Beach Resort - 1111 N. Ocean Drive, Hollywood, FL 33019

WHEN:            September 7-8, 2022

 

About the National Investment Banking Association

Since 1982, The National Investment Banking Association (NIBA) has been serving the micro-cap and small-cap investment community. NIBA has hosted 147 investment conferences showcasing public and private companies seeking access to the financial industry. The NIBA network has raised over $30 billion and is responsible for 90% of all IPOs under $20 million. NIBA is made up of thousands of investment professionals representing over 60 key industry services and includes over 8,800 registered representatives that have over $89 billion in assets under management.

About Tivic Health

Tivic Health Systems, Inc. is a commercial-phase health technology company delivering non-invasive bioelectronic treatments that provide consumers a choice in the treatment of inflammation and related conditions. For more information visit https://tivichealth.com @TivicHealth.

 

Forward-Looking Statements

This press release may contain “forward-looking statements” that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “believe,” “contemplate,” “could,” “estimate,” “expect,” “intend,” “seek,” “may,” “might,” “plan,” “potential,” “predict,” “project,” “target,” “aim,” “should,” “will” “would,” or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Tivic Health Systems, Inc.’s current expectations and are subject to inherent uncertainties, risks, and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Additional information concerning Tivic Health and its business, including a discussion of factors that could materially affect the company operating results, is contained in the company’s Annual Report on Form 10-K for the year ended December 31, 2021, filed with the Securities and Exchange Commission on March 31, 2022, under the heading “Risk Factors,” as well as the company’s subsequent filings with the Securities and Exchange Commission. Forward-looking statements contained in this press release are made as of this date, and Tivic Health Systems, Inc. undertakes no duty to update such information except as required by applicable law.


Investor Contact:
Hanover International, Inc.
ir@tivichealth.com

 

Media Contact:                                                           

Tivic Health
Cheryl Delgreco
Cheryl.Delgreco@tivichealth.com
617-723-4004

 

 

 

 

blank